News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Industry News Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients October 30, 2013
News Industry News Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test April 16, 2013
News Industry News 8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012 October 25, 2012
News Industry News Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT November 08, 2011
News Industry News 2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery March 08, 2011